2014
DOI: 10.1111/ijlh.12183
|View full text |Cite
|
Sign up to set email alerts
|

Application of bone marrow samples for discrimination of acute promyelocytic leukemia from other types of acute leukemia using the routine automated hematology analyzer

Abstract: Delta neutrophil index and LUC in BM showed discriminating power of APL cells from other leukemia cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
13
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 14 publications
0
13
0
Order By: Relevance
“…Another study led to design of a diagnostic algorithm for APL using as parameters the percentage of large unstained cells (LUC) and delta neutrophil index (DNI), but this work has been done on bone marrow aspiration fluid …”
Section: Introductionmentioning
confidence: 99%
“…Another study led to design of a diagnostic algorithm for APL using as parameters the percentage of large unstained cells (LUC) and delta neutrophil index (DNI), but this work has been done on bone marrow aspiration fluid …”
Section: Introductionmentioning
confidence: 99%
“…The qualitative review of cytogram 'morphology' performed to assist in the identification of cellular abnormalities is a well-known example of how automated haematology analysers changed laboratory practice during the past decades [2]. As a matter of fact, cytogram interpretation has been traditionally included in differential diagnostic procedures used to distinguish between acute myeloid and lymphoid leukaemias [3,4], which could be regarded as distinct entities from molecular, cellular and clinical perspectives [5,6]. Indeed, except for cases with pathognomonic morphological features (e.g.…”
mentioning
confidence: 99%
“…Sir, we would like to join d'Onofrio & Zini [1] in congratulating Jang et al upon their recent publication [2]. The ability of modern analytical platforms to offer clues to the potential diagnosis of acute promyelocytic leukemia (APL) should not be overlooked.…”
mentioning
confidence: 99%